Treatment outcomes after radiofrequency ablation in patients with non-B non-C hepatocellular carcinoma within Milan criteria: comparison with HBV-related hepatocellular carcinoma

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi: 10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Bertuccio P, Turati F, Carioli G, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol. 2017;67(2):302–309. doi: 10.1016/j.jhep.2017.03.011.
   PubMed Web of Science ®Google Scholar
• Tateishi R, Uchino K, Fujiwara N, et al. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update. J Gastroenterol. 2019;54(4):367–376. doi: 10.1007/s00535-018-1532-5.
   PubMed Web of Science ®Google Scholar
• Lee SB, Kim KM, An J, et al. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int. 2016;36(9):1351–1361. doi: 10.1111/liv.13099.
   PubMed Web of Science ®Google Scholar
• Lee SS, Jeong SH, Byoun YS, et al. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma. BMC Cancer. 2013;13:335. doi: 10.1186/1471-2407-13-335.
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255. doi: 10.1016/S0140-6736(11)61347-0.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. and American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022. doi: 10.1002/hep.24199.
   PubMed Web of Science ®Google Scholar
• Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017;66(6):1172–1173. doi: 10.1136/gutjnl-2016-312629.
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Piscaglia F, Cescon M, et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013;59(2):300–307. doi: 10.1016/j.jhep.2013.04.009.
   PubMed Web of Science ®Google Scholar
• Kondo K, Chijiiwa K, Funagayama M, et al. Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery. J Gastrointest Surg. 2008;12(3):468–476. doi: 10.1007/s11605-007-0402-x.
   PubMed Web of Science ®Google Scholar
• Li T, Qin LX, Gong X, et al. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer. 2013;119(1):126–135. doi: 10.1002/cncr.27697.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Arimoto A, Wakasa T, et al. Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma. J Cancer. 2013;4(6):502–513. doi: 10.7150/jca.6503.
   PubMed Web of Science ®Google Scholar
• Wu SS, Shan QY, Xie WX, et al. Outcomes after hepatectomy of patients with positive HBcAb non-B non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma. Clin Transl Oncol. 2020;22(3):401–410. doi: 10.1007/s12094-019-02141-8.
   PubMed Web of Science ®Google Scholar
• Xue X, Liao W, Xing Y. Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma. Infect Agent Cancer. 2020;15:11. doi: 10.1186/s13027-020-0273-2.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421–430. doi: 10.1016/s0168-8278(01)00130-1.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):s199–s202. doi: 10.1097/01.rvi.0000094584.83406.3e.
   PubMed Web of Science ®Google Scholar
• Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–540. doi: 10.1148/radiol.2021203715.
   PubMed Web of Science ®Google Scholar
• Utsunomiya T, Shimada M, Kudo M, et al. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg. 2015;261(3):513–520. doi: 10.1097/SLA.0000000000000821.
   PubMed Web of Science ®Google Scholar
• Takeishi K, Maeda T, Shirabe K, et al. Clinicopathologic features and outcomes of non-B, non-C hepatocellular carcinoma after hepatectomy. Ann Surg Oncol. 2015;*22 Suppl 3:S1116–S1124. doi: 10.1245/s10434-015-4728-4.
   PubMed Web of Science ®Google Scholar
• Tokushige K, Hashimoto E, Horie Y, et al. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol. 2011;46(10):1230–1237. doi: 10.1007/s00535-011-0431-9.
   PubMed Web of Science ®Google Scholar
• Hermida M, Cassinotto C, Piron L, et al. Multimodal percutaneous thermal ablation of small hepatocellular carcinoma: predictive factors of recurrence and survival in western patients. Cancers. 2020;12:313. doi: 10.3390/cancers12020313.
   Web of Science ®Google Scholar
• Lee MW, Kang D, Lim HK, et al. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival. Eur Radiol. 2020;30(4):2391–2400. doi: 10.1007/s00330-019-06575-0.
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–171. doi: 10.1097/01.sla.0000171032.99149.fe.
   PubMed Web of Science ®Google Scholar
• Shi M, Zhang CQ, Zhang YQ, et al. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg. 2004;28(4):376–381. doi: 10.1007/s00268-003-7308-x.
   PubMed Web of Science ®Google Scholar
• Shiina S, Tateishi R, Imamura M, et al. Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors. Liver Int. 2012;32(9):1434–1442. doi: 10.1111/j.1478-3231.2012.02838.x.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Abd El Aziz MA, Tartaglia N, et al. Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Cancers. 2020;12:3796. doi: 10.3390/cancers12123796.
   Web of Science ®Google Scholar
• Long HY, Zhuang BW, Huang GL, et al. Safety and local efficacy of laser ablation for the extrahepatic metastasis of hepatocellular carcinoma: an available treatment strategy. Coatings. 2020;10(10):951. doi: 10.3390/coatings10100951.
   Web of Science ®Google Scholar
• Liu BX, Wei MC, Liu FR, et al. Radiofrequency ablation plus nucleotide analogous for hepatitis B virus-related hepatocellular carcinoma: a cost-effectiveness analysis. Am J Transl Res. 2018;10:2685–2695.
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Friedman SL, Goossens N, et al. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68(3):526–549. doi: 10.1016/j.jhep.2017.09.016.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Abd El Aziz MA, Singh S, et al. Statin use decreases the incidence of hepatocellular carcinoma: an updated meta-analysis. Cancers. 2020;12:874. doi: 10.3390/cancers12040874.
   Web of Science ®Google Scholar
• Ramai D, Singh J, Lester J, et al. Systematic review with meta-analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma. Aliment Pharmacol Ther. 2021;53:977–984.
   PubMed Web of Science ®Google Scholar
• Wu LL, Hsieh MC, Chow JM, et al. Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients. Medicine (Baltimore). 2016;95(36):e4639. doi: 10.1097/MD.0000000000004639.
   PubMed Web of Science ®Google Scholar
• Amemiya H, Matsuda M, Saito R, et al. Impact of insulin treatment on prognosis of non-B non-C hepatocellular carcinoma after hepatectomy. Anticancer Res. 2021;41(1):317–326. doi: 10.21873/anticanres.14778.
   PubMed Web of Science ®Google Scholar